IPO Boutique

Amphastar Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Amphastar Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Amphastar PharmaceuticalsAMPH -
NASDAQ
$10.00-$12.00 $7.00 $7.008 million6/25/2014
Jefferies, BMO Capital Markets, Piper Jaffray
Co-Manager(s):
Needham & Company
Health Care
Filing(s):

Filed 2014-05-20
Terms Added 2014-06-13



Amphastar Pharmaceuticals Quote & Chart - Click for current quote - AMPH

About Amphastar Pharmaceuticals (adapted from Amphastar Pharmaceuticals prospectus):
They are a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling technically-challenging generic and proprietary injectable and inhalation products.

This description is adapted from Amphastar Pharmaceuticals prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Amphastar Pharmaceuticals "AMPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved